Industry Trends: The performance of the broader biotechnology sector and specifically companies focused on similar drug development areas will influence investor sentiment towards AMLH.US.

Clinical Trial Results: Positive or negative data from AMLH.US's clinical trials for its drug candidates are key catalysts for stock price movements. Successful results typically lead to price increases, while failures can cause significant declines.

Regulatory Approvals: Decisions by regulatory agencies such as the FDA regarding the approval of AMLH.US's drugs have a major impact on investor confidence and stock value.

Financial Performance: The company's cash position, burn rate, and ability to raise capital will be closely monitored by investors and affect the stock price.

Market Sentiment: Overall market conditions, investor risk appetite, and economic outlook can influence trading activity and valuations of companies like AMLH.US.

Competition: The competitive landscape for similar drugs in development or already on the market can impact AMLH.US's potential market share and thus its stock price.

Partnerships and Collaborations: Strategic alliances or partnerships with larger pharmaceutical companies can provide validation and financial resources, positively impacting the stock.

Management Team: The experience and expertise of the company's leadership team influence investor confidence in their ability to execute the business plan and deliver results.

News and Announcements: Corporate announcements regarding business updates, research findings, and future plans can trigger immediate price reactions.